Back Talk

AI Drug Design Could Save Lives

AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.

Digital Healthcare: Is It For Real?

The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.

How Do Docs Learn About New Drugs? TV, Of Course

If asked, some will equivocate and say they get their facts from medical journals and from published studies, but never from those pesky misleading ads.

How to Shatter the Glass Ceiling

Healthcare marketing has a head start in grooming women leaders. But it's by no means a fait accompli.

Who Needs a Gold Watch, Anyway?

Perhaps we should always bear in mind the need to periodically reinvigorate and reshape our careers.

Quitting Your Job: Dramatic Exit or Inappropriate?

Apologies to Paul Simon, but there must be 50 ways to leave your employer.

When It Comes to the FDA, Does It All Come Down to Money?

In our struggle with the bean counters and the stockbrokers, can't we make patient needs a priority, too?

Is the Trump Administration the Cure the FDA Needs?

Finally, a Congress and president who see pharma as a resource and not a villain, Flaum writes.

Harness the Power of Paranoia to Disrupt Your Business

In short, CEOs can't be afraid to walk away from their most profitable line if another approach may lead to improved long-term outcomes.

Paying Lip Service to STEM Isn't Enough

I'm not suggesting that colleges become vocational schools. But don't you think they should also help young people prepare for the life they're going to be living?